黑料网 Researchers Philpot, Zylka and Roth are awarded a prestigious grant from the Simons Foundation for research in autism spectrum disorders
February 2011 鈥� Drs. Ben Philpot, Mark Zylka, and Bryan Roth were awarded a prestigious grant from the Simons Foundation to identify drug-like compounds for the treatment of autism spectrum disorders. This research includes work with an animal model of Angelman syndrome, a neurodevelopmental disorder caused by inactivation of the Ube3a gene. Drs. Philpot, Zylka and Roth are affiliated with the Carolina Institute for Developmental Disabilities, 黑料网 Neuroscience Center, the Department of Cell and Molecular Physiology (Philpot, Zylka) and the Department of Pharmacology (Roth).
Further details can be found at the . Also see the lab websites for Drs. Philpot, Zylka, and Roth.